1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Summary of 13 patients with meningioma embolized with hydroxyapatite microparticles
No. Patient Age (yr)/Sex Location Feeders Embolized with HAP (Embolization Grade) 1 35/F Vault MMA-p (A) 2 55/M Vault MMA-p (A) 3 59/F Vault MMA-a (A) 4 63/M Vault MMA-a (A), MMA-p (A), AMA (A) 5 64/M Vault MMA-a (A), MMA-p (A) 6 73/M Vault MMA (A), AMA (A) 7 41/F Sphenoidal ridge MMA-a (A) 8 44/F Sphenoidal ridge MMA-a (A), MMA-p (A) 9 53/F Sphenoidal ridge MMA-a (A), AMA (A) 10 65/M Parasagittal MMA (A) 11 66/M Parasagittal MMA-a (A), MMA-p (A) 12 66/M Parasagittal MMA-p (A) 13 53/F Falx MMA-a (A)
Note.—HAP indicates hydroxyapatite; F, female; M, male; MMA-p, posterior branch of the middle meningeal artery; MMA-a, anterior branch of the middle meningcal artery; AMA, accessory meningeal artery.